Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AntiV-SGN: a universal antiviral strategy to combat both RNA and DNA viruses by destroying their nucleic acids without sequence limitation. | Microb Biotechnol | 2022 | 35611874 | PubTator, text mining | PubMed |
| Association between the genetic variants of base excision repair pathway genes and allergic rhinitis susceptibility in Chinese children. | World Allergy Organ J | 2022 | 35600838 | PubTator, text mining | PubMed |
| A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response. | Cell Rep Med | 2022 | 35584624 | PubTator, text mining | PubMed |
| DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis. | Front Aging Neurosci | 2022 | 35572138 | PubTator, text mining | PubMed |
| Identification of microRNA-mRNA regulatory network associated with oxidative DNA damage in human astrocytes. | ASN Neuro | 2022 | 35570825 | PubTator, text mining | PubMed |
| Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells. | Molecules | 2022 | 35566271 | PubTator, text mining | PubMed |
| VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway. | J Transl Med | 2022 | 35562734 | PubTator, text mining | PubMed |
| Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis. | EBioMedicine | 2022 | 35561450 | PubTator, text mining | PubMed |
| Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer. | Front Genet | 2022 | 35559045 | PubTator, text mining | PubMed |
| Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. | Cell Rep | 2022 | 35545034 | PubTator, text mining | PubMed |
| Pancreatic INS-1 β-Cell Response to Thapsigargin and Rotenone: A Comparative Proteomics Analysis Uncovers Key Pathways of β-Cell Dysfunction. | Chem Res Toxicol | 2022 | 35544339 | PubTator, text mining | PubMed |
| The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer. | Int J Biol Sci | 2022 | 35541906 | PubTator, text mining | PubMed |
| A FEN 1-assisted swing arm DNA walker for electrochemical detection of ctDNA by target recycling cascade amplification. | Anal Methods | 2022 | 35527509 | PubTator, text mining | PubMed |
| Study on Influencing Factors of Construction Workers' Unsafe Behavior Based on Text Mining. | Front Psychol | 2022 | 35519654 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Walking a tightrope: The complex balancing act of R-loops in genome stability. | Mol Cell | 2022 | 35508167 | PubTator, text mining | PubMed |
| METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis. | Elife | 2022 | 35502895 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1. | Bioengineered | 2022 | 35502827 | PubTator, text mining | PubMed |
| DNA repair and damage pathways in mesothelioma development and therapy. | Cancer Cell Int | 2022 | 35501851 | PubTator, text mining | PubMed |
| Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer. | Front Endocrinol (Lausanne) | 2022 | 35498431 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=43